Subphenotype 2 also consisted of older patients, but with lower SBP, more comorbidities such as diabetes mellitus and chronic renal failure, very high NT-proBNP and hs-troponin, and worse clinical outcomes. This evidence concerns the gene NPPB and chronic kidney disease.